Majd A. Al‐Hamaly

This study identifies NHE1 as a regulator of T-ALL leukemia-propagating activity and mitochondrial fitness, showing its therapeutic potential.

This study shows that sEVs from radioresistant H3K27M-pDMG cells protect radiosensitive cells from radiation by altering metabolism and DNA repair.

This study shows PRL-3 promotes cancer without needing its phosphatase activity, using zebrafish and cell line models, and suggests targeting its protein interactions as a therapy.

This study identifies Erlotinib as a Wnt/β-catenin inhibitor effective in zebrafish and human cells, reducing leukemia-initiating cell self-renewal and disease progression.